# LACOSAMIDE
> **ANDA220366** · Abbreviated New Drug Application (Generic) · Sponsor: STERANCO HLTHCARE · Approved 2026-05-21
## Drug
- **FDA Application Number:** ANDA220366
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LACOSAMIDE
- **Generic name:** Lacosamide
- **Active ingredients:** LACOSAMIDE
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** STERANCO HLTHCARE
- **First approval:** 2026-05-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220366)
---
*MORVS · CC0 1.0*